Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells
- PMID: 15196265
- PMCID: PMC1809094
- DOI: 10.1111/j.1365-2249.2004.02496.x
Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells
Abstract
Maternal anti-HPA-1a antibodies can cause severe fetal and neonatal alloimmune thrombocytopenia (FNAIT), complicated by intracranial haemorrhage (ICH). Antenatal treatment with maternal intravenous immunoglobulin (IVIG) seems to protect against ICH even when thrombocytopenia persists. The aim of this study was to investigate if anti-HPA-1a antibodies and IVIG potentially affect vascular endothelial cells (ECs) in order to identify susceptibility for ICH. Human umbilical cord endothelial cells (HUVEC) were incubated with anti-HPA-1a antibodies with or without polyclonal IVIG and evaluated for EC activation. Maternal sera with anti-HPA-1a antibodies affected neither the EC expression of intracellular adhesion molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1) and tissue factor (TF) nor the release of van Willebrand factor (vWF) or interleukin (IL)-8 nor the integrity of ECs. Maternal sera obtained after IVIG treatment and polyclonal IVIG decrease constitutive and cytokine-induced ICAM-1 and VCAM-1 expression on ECs. The results show that maternal anti-HPA-1a antibodies cause no activation or damage of ECs in this model. The clinical relevance of the de-activating properties of IVIG on EC activation with respect to ICH deserves further investigation.
Figures


Similar articles
-
Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune Thrombocytopenia.Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1517-24. doi: 10.1161/ATVBAHA.116.307281. Epub 2016 Jun 9. Arterioscler Thromb Vasc Biol. 2016. PMID: 27283740 Free PMC article.
-
Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.J Clin Invest. 2015 Apr;125(4):1545-56. doi: 10.1172/JCI77820. Epub 2015 Mar 16. J Clin Invest. 2015. PMID: 25774504 Free PMC article.
-
Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.Transfusion. 2016 Jan;56(1):59-66; quiz 58. doi: 10.1111/trf.13274. Epub 2015 Sep 7. Transfusion. 2016. PMID: 26469867
-
Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1b: Case report and literature review.Transfus Med. 2022 Aug;32(4):269-275. doi: 10.1111/tme.12892. Epub 2022 Jun 22. Transfus Med. 2022. PMID: 35730350 Review.
-
Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.Transfus Apher Sci. 2020 Feb;59(1):102712. doi: 10.1016/j.transci.2019.102712. Epub 2019 Dec 31. Transfus Apher Sci. 2020. PMID: 31948915 Review.
Cited by
-
Th17 cells reflect colon submucosal pathologic changes in active eosinophilic granulomatosis with polyangiitis.BMC Immunol. 2015 Dec 29;16:75. doi: 10.1186/s12865-015-0138-4. BMC Immunol. 2015. PMID: 26714881 Free PMC article.
-
Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG.Eur J Pediatr. 2007 Oct;166(10):1057-63. doi: 10.1007/s00431-006-0389-4. Epub 2006 Dec 20. Eur J Pediatr. 2007. PMID: 17177068
-
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.Front Immunol. 2020 Jul 14;11:1660. doi: 10.3389/fimmu.2020.01660. eCollection 2020. Front Immunol. 2020. PMID: 32760407 Free PMC article. Review.
-
Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.J Clin Invest. 2008 Aug;118(8):2929-38. doi: 10.1172/JCI34708. J Clin Invest. 2008. PMID: 18654666 Free PMC article.
-
Effect of Peptides from Plasma of Patients with Coronary Artery Disease on the Vascular Endothelial Cells.Medicina (Kaunas). 2023 Jan 27;59(2):238. doi: 10.3390/medicina59020238. Medicina (Kaunas). 2023. PMID: 36837440 Free PMC article.
References
-
- Mueller-Eckhardt C, Kiefel V, Grubert A, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet. 1989;1:363–6. - PubMed
-
- Porcelijn L, Kanhai HH. Diagnosis and management of fetal platelet disorders. In: Rodeck CH, Whittle MJ, editors. Fetal medicine: basic science and clinical practice. London: Churchill Livingstone; 1999. pp. 805–15.
-
- Leeksma OC, Zandbergen-Spaargaren J, Giltay JC, van Mourik JA. Cultured human endothelial cells synthesize a plasma membrane protein complex immunologically related to the platelet glycoprotein IIb/IIIa complex. Blood. 1986;67:1176–80. - PubMed
-
- Valentin N, Visentin GP, Newman PJ. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response. Blood. 1995;85:3028–33. - PubMed
-
- Gruel Y, Boizard B, Daffos F, Forestier F, Caen J, Wautier JL. Determination of platelet antigens and glycoproteins in the human fetus. Blood. 1986;68:488–92. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous